However, the analgesic effects of liraglutide were not observed in GSK3 (S9A) mice, indicating that liraglutide relieved diabetic pain by suppressing the NLRP3 inflammasome in microglia through GSK3 [84]
In addition, the baseline covariates after matching were fully balanced
However, these peripheral effects do not translate into increased food intake or body weight within 24 h following GLP-1 receptor blockade.43,44 Collectively, these findings support the notion that brain GLP-1 receptors regulate feeding behavior and body weight,3,20,24 complementing the limited phagocytosis of endogenous GLP-1 via peripheral receptors.45 Given the rapid degradation of endogenous GLP-1 upon entering circulation, hypothalamic GLP-1 receptors are likely predominantly activated by GLP-1 neurons originating in the NTS.32 Importantly, recently developed long-acting GLP-1 analogs have been demonstrated to target multiple brain nuclei, including the hypothalamus, thereby expanding the therapeutic potential of GLP-1-based interventions36,46 (See Figure 1)

Your Options Request a formulary exception your doctor can argue medical necessity What to do if Wegovy is not covered Cardiovascular risk reduction if you have heart disease risk factors, Wegovy's FDA-approved indication (March 2024) strengthens your case Consider Zepbound as of October 1, 2026 it returns as an "additional preferred option" alongside Wegovy on most Aetna/CVS Caremark plans [10] Zepbound coverage on Aetna Switch plans during open enrollment if your employer offers multiple options, check for GLP-1 coverage Explore self-pay options NovoCare ($349/mo) and patient assistance may help Wegovy Cost Guide About Wegovy's FDA Approvals Important: Sleep Apnea Coverage Goes to Zepbound, Not Wegovy Note: Zepbound (tirzepatide), not Wegovy, was FDA-approved to treat obstructive sleep apnea (OSA) in adults with obesity on December 20, 2024
If hCG is present, you should get a positive test result when you pee on a stick